APA Zitierstil

Fukamachi, H., Kim, S., Koh, J., Lee, H. S., Sasaki, Y., Yamashita, K., . . . Tanaka, S. (2019). A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors. J Exp Clin Cancer Res.

Chicago Zitierstil

Fukamachi, Hiroshi, et al. "A Subset of Diffuse-type Gastric Cancer Is Susceptible to MTOR Inhibitors and Checkpoint Inhibitors." J Exp Clin Cancer Res 2019.

MLA Zitierstil

Fukamachi, Hiroshi, et al. "A Subset of Diffuse-type Gastric Cancer Is Susceptible to MTOR Inhibitors and Checkpoint Inhibitors." J Exp Clin Cancer Res 2019.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.